Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study

Abstract

Background: Poor access to essential medicines remains a barrier to improvement of health in low-income countries. The maternal mortality rate from post-partum haemorrhage (PPH) in Uganda is one of the highest in the world. Uganda launched a misoprostol rollout programme for prevention of PPH in 2009, before WHO added it to the Essential Medicines List. We assessed the rollout programme in Uganda.

Description

Citation

Atukunda, E. C., Brhlikova, P., Agaba, A. G., & Pollock, A. M. (2013). Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet, 382, 10.

Endorsement

Review

Supplemented By

Referenced By